-
1
-
-
34447580751
-
Ministère de la Santé. Programme National de Lutte contre le Paludisme. 2001. Plan stratégique pour faire reculer le paludisme au Sénégal 2001-2005
-
Ministère de la Santé. Programme National de Lutte contre le Paludisme. 2001. Plan stratégique pour faire reculer le paludisme au Sénégal 2001-2005. Janvier 2001
-
(2001)
Janvier
-
-
-
2
-
-
0035806761
-
Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: A randomised trial
-
10.1016/S0140-6736(01)05557-X. 11502317
-
Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial. SG Staedke MR Kamya G Dorsey A Gasasira G Ndeezi ED Charlebois PJ Rosenthal, Lancet 2001 358 368 374 10.1016/S0140-6736(01)05557-X 11502317
-
(2001)
Lancet
, vol.358
, pp. 368-374
-
-
Staedke, S.G.1
Kamya, M.R.2
Dorsey, G.3
Gasasira, A.4
Ndeezi, G.5
Charlebois, E.D.6
Rosenthal, P.J.7
-
3
-
-
1342280397
-
Efficacy of sulphadoxine-pyrimethamine alone or combined with amodiaquine or chloroquine for the treatment of uncomplicated falciparum malaria in Ugandan children
-
10.1046/j.1365-3156.2003.01187.x
-
Efficacy of sulphadoxine-pyrimethamine alone or combined with amodiaquine or chloroquine for the treatment of uncomplicated falciparum malaria in Ugandan children. AO Talisuna A Nalunkuma-Kazibwe N Bakyaita P Langi TK Mutabingwa WW Watkins E Van Marck U D'Alessandro G Egwang, Trop Med Int 2004 9 222 229 10.1046/j.1365-3156.2003.01187.x
-
(2004)
Trop Med Int
, vol.9
, pp. 222-229
-
-
Talisuna, A.O.1
Nalunkuma-Kazibwe, A.2
Bakyaita, N.3
Langi, P.4
Mutabingwa, T.K.5
Watkins, W.W.6
Van Marck, E.7
D'Alessandro, U.8
Egwang, G.9
-
4
-
-
34447546414
-
Les combinaisons thérapeutiques d'antipaludiques. Rapport d'une consultation technique
-
Les combinaisons thérapeutiques d'antipaludiques. Rapport d'une consultation technique. OMS/WHO, WHO/CDS/RBM/2001.35
-
WHO/CDS/RBM/2001.35
-
-
-
5
-
-
34447575536
-
Monitoring antimalarial drug resistance
-
Monitoring antimalarial drug resistance. OMS/WHO, CS/CSR/EPH/2002.17
-
CS/CSR/EPH/2002.17
-
-
-
6
-
-
34447541891
-
Place des bithérapies en zones de chimiorésistance au Sénégal
-
Place des bithérapies en zones de chimiorésistance au Sénégal. B Faye Y Dieng I Ndir M Mbengue O Faye O Ndir O Gaye, Communication 5eme Congrès de la Société Ouest Africaine de Parasitologie, Dakar 2002
-
(2002)
Communication 5eme Congrès de la Société Ouest Africaine de Parasitologie, Dakar
-
-
Faye, B.1
Dieng, Y.2
Ndir, I.3
Mbengue, M.4
Faye, O.5
Ndir, O.6
Gaye, O.7
-
7
-
-
0033048031
-
A randomised, double-blind, comparative trial of a new oral combination of artemether and benflumetol (CPG 56697) with mefloquine in the treatment of acute Plasmodium falciparum malaria in Thailand
-
10072142
-
A randomised, double-blind, comparative trial of a new oral combination of artemether and benflumetol (CPG 56697) with mefloquine in the treatment of acute Plasmodium falciparum malaria in Thailand. S Looareesuwan P Wilairatana W Chokejindachai, Am J Trop Med Hyg 1999 60 238 243 10072142
-
(1999)
Am J Trop Med Hyg
, vol.60
, pp. 238-243
-
-
Looareesuwan, S.1
Wilairatana, P.2
Chokejindachai, W.3
-
8
-
-
0031973150
-
Randomized comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multidrug-resistant falciparum malaria
-
9449273
-
Randomized comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multidrug-resistant falciparum malaria. M Van Vugt A Brockman B Gemperli C Luxemburger I Gathmann C Royce Slight Thra S Looareesuwan NJ White F Nostens, Antimicrob Agents Chemother 1998 42 135 139 9449273
-
(1998)
Antimicrob Agents Chemother
, vol.42
, pp. 135-139
-
-
Van Vugt, M.1
Brockman, A.2
Gemperli, B.3
Luxemburger, C.4
Gathmann, I.5
Royce, C.6
Thra, S.7
Looareesuwan, S.8
White, N.J.9
Nostens, F.10
-
9
-
-
0033027432
-
Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria
-
10403324
-
Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria. M Van Vugt P Wilairatana B Gemperli I Gathmann L Phaipun A Brockman C Luxemburger NJ White F Nosten S Looareesuwan, Am J Trop Med Hyg 1999 60 936 942 10403324
-
(1999)
Am J Trop Med Hyg
, vol.60
, pp. 936-942
-
-
Van Vugt, M.1
Wilairatana, P.2
Gemperli, B.3
Gathmann, I.4
Phaipun, L.5
Brockman, A.6
Luxemburger, C.7
White, N.J.8
Nosten, F.9
Looareesuwan, S.10
-
10
-
-
0033784974
-
Artemether-lumefantrine for the treatment of multidrug- resistant falciparum malaria
-
10.1016/S0035-9203(00)90082-8. 11132386
-
Artemether-lumefantrine for the treatment of multidrug- resistant falciparum malaria. M Van Vugt S Looareesuwan P Wilairatana R Mc Gready L Villegas I Gathmann R Mull A Brockman NJ White F Nosten, Trans R Soc Trop Med Hyg 2000 94 545 548 10.1016/S0035-9203(00)90082-8 11132386
-
(2000)
Trans R Soc Trop Med Hyg
, vol.94
, pp. 545-548
-
-
Van Vugt, M.1
Looareesuwan, S.2
Wilairatana, P.3
Mc Gready, R.4
Villegas, L.5
Gathmann, I.6
Mull, R.7
Brockman, A.8
White, N.J.9
Nosten, F.10
-
11
-
-
0036316594
-
Therapeutic efficacy ofsulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon
-
12163917
-
Therapeutic efficacy ofsulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon. LK Basco A Same-Ekobo NV Foumane M Ndounga T Metoh P Ringwald G Soula, Bull World Health Organ 2002 80 538 545 12163917
-
(2002)
Bull World Health Organ
, vol.80
, pp. 538-545
-
-
Basco, L.K.1
Same-Ekobo, A.2
Foumane, N.V.3
Ndounga, M.4
Metoh, T.5
Ringwald, P.6
Soula, G.7
-
12
-
-
0037153723
-
Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: A longitudinal randomised trial
-
10.1016/S0140-6736(02)12021-6. 12504399
-
Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial. G Dorsey D Njama MR Kamya A Cattamanchi D Kyabayinze SG Staedke A Gasasira PJ Rosenthal, Lancet 2002 360 2031 2038 10.1016/S0140-6736(02)12021-6 12504399
-
(2002)
Lancet
, vol.360
, pp. 2031-2038
-
-
Dorsey, G.1
Njama, D.2
Kamya, M.R.3
Cattamanchi, A.4
Kyabayinze, D.5
Staedke, S.G.6
Gasasira, A.7
Rosenthal, P.J.8
-
13
-
-
0036655646
-
The safety and efficacy of sulfadoxine-pyrimethamine, amodiaquine, and their combination in the treatment of uncomplicated Plasmodium falciparum malaria
-
12363058
-
The safety and efficacy of sulfadoxine-pyrimethamine, amodiaquine, and their combination in the treatment of uncomplicated Plasmodium falciparum malaria. D Schellenberg E Kahigwa C Drakeley A Malende J Wigayi C Msokame JJ Aponte M Tanner H Mshinda C Menendez PL Alonso, Am J Trop Med Hyg 2002 67 17 23 12363058
-
(2002)
Am J Trop Med Hyg
, vol.67
, pp. 17-23
-
-
Schellenberg, D.1
Kahigwa, E.2
Drakeley, C.3
Malende, A.4
Wigayi, J.5
Msokame, C.6
Aponte, J.J.7
Tanner, M.8
Mshinda, H.9
Menendez, C.10
Alonso, P.L.11
-
14
-
-
17844404530
-
Amodiaquine alone, amodiaquine + sulfadoxine-pyrimethamine, amodiaquine + artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: A four-arm randomised effectiveness trial
-
10.1016/S0140-6736(05)66417-3. 15850631
-
Amodiaquine alone, amodiaquine + sulfadoxine-pyrimethamine, amodiaquine + artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial. TK Mutabingwa D Anthony A Heller R Hallett J Ahmed C Drakeley BM Greenwood CJ Whitty, Lancet 2005 365 1474 1480 10.1016/S0140-6736(05)66417-3 15850631
-
(2005)
Lancet
, vol.365
, pp. 1474-1480
-
-
Mutabingwa, T.K.1
Anthony, D.2
Heller, A.3
Hallett, R.4
Ahmed, J.5
Drakeley, C.6
Greenwood, B.M.7
Whitty, C.J.8
-
15
-
-
27844540752
-
Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroase synthetase genes in Sénégal
-
10.1111/j.1365-3156.2005.01506.x. 16262743
-
Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroase synthetase genes in Sénégal. D Ndiaye JP Daily O Sarr O Ndir O Gaye S Mboup DF Wirth, Trop Med Int Health 2005 10 1176 1179 10.1111/j.1365-3156.2005.01506.x 16262743
-
(2005)
Trop Med Int Health
, vol.10
, pp. 1176-1179
-
-
Ndiaye, D.1
Daily, J.P.2
Sarr, O.3
Ndir, O.4
Gaye, O.5
Mboup, S.6
Wirth, D.F.7
-
16
-
-
2342655061
-
A randomized trial of amodiaquine and artesunate alone and in combination for the treatment of uncomplicated Falciparum malaria in children from Burkina Faso
-
10.1111/j.1365-3156.2004.01224.x. 15078261
-
A randomized trial of amodiaquine and artesunate alone and in combination for the treatment of uncomplicated Falciparum malaria in children from Burkina Faso. H Barennes N Nagot I Valea T Koussoubé-Balima A Ouedraogo T Sanou S Yé Trop Med Int Health 2004 9 438 444 10.1111/j.1365-3156.2004.01224.x 15078261
-
(2004)
Trop Med Int Health
, vol.9
, pp. 438-444
-
-
Barennes, H.1
Nagot, N.2
Valea, I.3
Koussoubé-Balima, T.4
Ouedraogo, A.5
Sanou, T.6
Yé, S.7
-
17
-
-
0032960336
-
Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives
-
10348227
-
Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives. R Price M Van Vugt L Phaipun C Luxemburger J Simpson R Mcgready F Ter Kuile K Am T Chongsuphajaisiddhi NJ White F Nosten, Am J Trop Med Hyg 1999 60 547 555 10348227
-
(1999)
Am J Trop Med Hyg
, vol.60
, pp. 547-555
-
-
Price, R.1
Van Vugt, M.2
Phaipun, L.3
Luxemburger, C.4
Simpson, J.5
McGready, R.6
Ter Kuile, F.7
Am, K.8
Chongsuphajaisiddhi, T.9
White, N.J.10
Nosten, F.11
-
18
-
-
0037140198
-
Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: A randomised, multicentre trial
-
10.1016/S0140-6736(02)08348-4. 11978332
-
Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial. M Adjuik P Agnamey A Babiker S Borrmann P Brasseur M Cisse F Cobelens S Diallo JF Faucher P Garner S Gikunda PG Kremsner S Krishna B Lell M Loolpapit PB Matsiegui MA Missinou J Mwanza F Ntoumi P Olliaro P Osimbo P Rezbach E Some WRJ Taylor, Lancet 2002 359 1365 72 10.1016/S0140-6736(02)08348-4 11978332
-
(2002)
Lancet
, vol.359
, pp. 1365-72
-
-
Adjuik, M.1
Agnamey, P.2
Babiker, A.3
Borrmann, S.4
Brasseur, P.5
Cisse, M.6
Cobelens, F.7
Diallo, S.8
Faucher, J.F.9
Garner, P.10
Gikunda, S.11
Kremsner, P.G.12
Krishna, S.13
Lell, B.14
Loolpapit, M.15
Matsiegui, P.B.16
Missinou, M.A.17
Mwanza, J.18
Ntoumi, F.19
Olliaro, P.20
Osimbo, P.21
Rezbach, P.22
Some, E.23
Taylor, W.R.J.24
more..
|